Literature DB >> 26289849

Letter regarding Zhang et al. entitled "Systematic review of high-dose and standard-dose chemotherapies in the treatment of primary well-differentiated osteosarcoma".

Ke-Wei Zhu1, Wan-Chun Wang1, Ren Wu1, Ding Chen2.   

Abstract

Entities:  

Keywords:  Letter; Primary well-differentiated osteosarcoma; Systematic review

Mesh：

Year:  2015        PMID： 26289849     DOI： 10.1007/s13277-015-3910-4

Source DB:  PubMed          Journal:  Tumour Biol        ISSN： 1010-4283


× No keyword cloud information.
  6 in total

1.  Randomised trial of two regimens of chemotherapy in operable osteosarcoma: a study of the European Osteosarcoma Intergroup.

Authors:  R L Souhami; A W Craft; J W Van der Eijken; M Nooij; D Spooner; V H Bramwell; R Wierzbicki; A J Malcolm; A Kirkpatrick; B M Uscinska; M Van Glabbeke; D Machin
Journal:  Lancet       Date:  1997-09-27       Impact factor: 79.321

Review 2.  Systematic review of high-dose and standard-dose chemotherapies in the treatment of primary well-differentiated osteosarcoma.

Authors:  Fu-You Zhang; Wei Tang; Zhi-Zhong Zhang; Jian-Cheng Huang; Shu-Xiang Zhang; Xue-Chun Zhao
Journal:  Tumour Biol       Date:  2014-07-23

3.  Dose-intensified compared with standard chemotherapy for nonmetastatic Ewing sarcoma family of tumors: a Children's Oncology Group Study.

Authors:  Linda Granowetter; Richard Womer; Meenakshi Devidas; Mark Krailo; Chenguang Wang; Mark Bernstein; Neyssa Marina; Patrick Leavey; Mark Gebhardt; John Healey; Robert Cooper Shamberger; Allen Goorin; James Miser; James Meyer; Carola A S Arndt; Scott Sailer; Karen Marcus; Elizabeth Perlman; Paul Dickman; Holcombe E Grier
Journal:  J Clin Oncol       Date:  2009-04-06       Impact factor: 44.544

4.  Neoadjuvant chemotherapy for osteosarcoma of the extremity: intensification of preoperative treatment does not increase the rate of good histologic response to the primary tumor or improve the final outcome.

Authors:  Gaetano Bacci; Cristiana Forni; Stefano Ferrari; Alessandra Longhi; Franco Bertoni; Mario Mercuri; Davide Donati; Rodolfo Capanna; Gabriella Bernini; Antonio Briccoli; Elisabetta Setola; Michela Versari
Journal:  J Pediatr Hematol Oncol       Date:  2003-11       Impact factor: 1.289

5.  Adriamycin-methotrexate high dose versus adriamycin-methotrexate moderate dose as adjuvant chemotherapy for osteosarcoma of the extremities: a randomized study.

Authors:  G Bacci; F Gherlinzoni; P Picci; J R Van Horn; N Jaffe; A Guerra; P Ruggieri; R Biagini; R Capanna; A Toni
Journal:  Eur J Cancer Clin Oncol       Date:  1986-11

6.  Intensification of preoperative chemotherapy for osteogenic sarcoma: results of the Memorial Sloan-Kettering (T12) protocol.

Authors:  P A Meyers; R Gorlick; G Heller; E Casper; J Lane; A G Huvos; J H Healey
Journal:  J Clin Oncol       Date:  1998-07       Impact factor: 44.544
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.